We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

BioCision Standardizes Histology Procedures with CoolSink™ H Line


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "BioCision Standardizes Histology Procedures with CoolSink™ H Line"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

At this week’s 2011 Annual Meeting of the American Society for Cell Biology (ASCB), BioCision has launched a novel and comprehensive line of products to standardize procedures related to immunohistochemistry, slide staining and sorting, tissue dissection, cell harvesting, and tissue embedding.

The response of ASCB attendees to the CoolSink H line - consisting of 10 new products - was overwhelmingly positive.

“These products will change the way tissue samples are prepared and have a huge impact on biomarker detection, especially in the new era of personalized medicine,” said BioCision’s CEO Rolf Ehrhardt, MD, PhD.

Ehrhardt continued, “Poor preparation, which is a common occurrence, can hasten the degradation of proteins and nucleic acids, and compromise ultrastructural fidelity. The CoolSink H line ensures stable, consistent and highly reproducible sample handling.”

In addition to the recently introduced HistoMailer™ biopsy cassette shipper, this new portfolio consists of seven thermo-conductive platforms to equalize temperature and provide an interface between the sample and temperature source, eliminating temperature variability.

CoolSink H modules accommodate a variety of commonly used histology vessels including slides, culture dishes, OCT blocks and others.

“BioCision has a proven track record in developing products to standardize and optimize the processing of cell samples,” said Hugh Douglas, BioCision’s Chief Operating Officer.

Douglas continued, “We are pleased to offer a new line of products that provides the same consistency, reproducibility and standardization in handling tissue samples.”

Advertisement